Margo Renee Rollins, Rahma Warsame, Melody Smith, Arturo Molina, Rayne H Rouce, Belinda R Avalos, Cage S Johnson, Jose A Lopez, Alexis A Thompson, Lisa Fanning, Patricia Frustace, Keelin Roche, Nathalie van Havre, Devon Mack, Christopher R Flowers, Deirdra R Terrell
{"title":"American Society of Hematology: Building a Comprehensive Minority Recruitment and Retention Professional Program.","authors":"Margo Renee Rollins, Rahma Warsame, Melody Smith, Arturo Molina, Rayne H Rouce, Belinda R Avalos, Cage S Johnson, Jose A Lopez, Alexis A Thompson, Lisa Fanning, Patricia Frustace, Keelin Roche, Nathalie van Havre, Devon Mack, Christopher R Flowers, Deirdra R Terrell","doi":"10.1182/bloodadvances.2024013519","DOIUrl":null,"url":null,"abstract":"<p><p>In 2003, the Institute of Medicine noted the need to improve workforce diversity. The American Society of Hematology (ASH) responded by developing the Minority Recruitment Initiative (MRI) to recruit diverse physicians/scientists into hematology. We evaluated the outcomes of the program. From 2004-2022, there were 405 awardees. Compared to national estimates, MRI awardees were less likely to discontinue their degree programs. MRI graduate student awardees 0% attrition (97.5% confidence interval (CI) 10.6%) while national minority graduate student attrition was 36%. Medical student awardees had 2.2% (95% CI 0.61%, 5.6%) attrition compared to minority medical school attrition of 5.6%. Awardees were more likely than expected to pursue hematology-oncology (5.7% minority national estimate) as 14.4% (95% CI 8.1%, 23.0%) of medical student awardees and 88.5% (95% CI 70.0%, 97.6%) of early career awardees remain in the field. ASH has developed a successful program, but continued efforts are needed to advance equity in hematology.</p>","PeriodicalId":9228,"journal":{"name":"Blood advances","volume":" ","pages":""},"PeriodicalIF":7.4000,"publicationDate":"2026-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Blood advances","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1182/bloodadvances.2024013519","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
In 2003, the Institute of Medicine noted the need to improve workforce diversity. The American Society of Hematology (ASH) responded by developing the Minority Recruitment Initiative (MRI) to recruit diverse physicians/scientists into hematology. We evaluated the outcomes of the program. From 2004-2022, there were 405 awardees. Compared to national estimates, MRI awardees were less likely to discontinue their degree programs. MRI graduate student awardees 0% attrition (97.5% confidence interval (CI) 10.6%) while national minority graduate student attrition was 36%. Medical student awardees had 2.2% (95% CI 0.61%, 5.6%) attrition compared to minority medical school attrition of 5.6%. Awardees were more likely than expected to pursue hematology-oncology (5.7% minority national estimate) as 14.4% (95% CI 8.1%, 23.0%) of medical student awardees and 88.5% (95% CI 70.0%, 97.6%) of early career awardees remain in the field. ASH has developed a successful program, but continued efforts are needed to advance equity in hematology.
期刊介绍:
Blood Advances, a semimonthly medical journal published by the American Society of Hematology, marks the first addition to the Blood family in 70 years. This peer-reviewed, online-only, open-access journal was launched under the leadership of founding editor-in-chief Robert Negrin, MD, from Stanford University Medical Center in Stanford, CA, with its inaugural issue released on November 29, 2016.
Blood Advances serves as an international platform for original articles detailing basic laboratory, translational, and clinical investigations in hematology. The journal comprehensively covers all aspects of hematology, including disorders of leukocytes (both benign and malignant), erythrocytes, platelets, hemostatic mechanisms, vascular biology, immunology, and hematologic oncology. Each article undergoes a rigorous peer-review process, with selection based on the originality of the findings, the high quality of the work presented, and the clarity of the presentation.